WHO ICTRP trial

A prospective, multi-center, randomized, concurrently-controlled clinical study…

DRKS00010189 · German Clinical Trials Register · Not Recruiting

Key facts

Trial ID DRKS00010189
Public title A prospective, multi-center, randomized, concurrently-controlled clinical study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft in the treatment of stenosis in the venous outflow of AV fistula access circuits (AVeNEW)
Scientific title A prospective, multi-center, randomized, concurrently-controlled clinical study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft in the treatment of stenosis in the venous outflow of AV fistula access circuits (AVeNEW) - AVeNEW
Primary sponsor Bard Peripheral Vascular, Inc.
Registry German Clinical Trials Register
Recruitment status Not Recruiting
Study type interventional
Countries Austria;Australia;Belgium;Switzerland;Germany;Netherlands;New Zealand;United States
Conditions Stenoses in the upper extremity venous outflow of patients dialyzing with an arterio-venous (AV) access fistula.
Interventions Group 1: Treatment with PTA (Percutaneous Transluminal Angioplasty) and BARD® COVERA™ Vascular Covered Stent Group 2: Treatment with PTA (Percutaneous Transluminal Angioplasty)
Registration date Jul 7, 2016
Target size 280
Secondary IDs NCT02649946
Registry page drks.de

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations